The current uncertainty surrounding the healthcare sector in the US could have adverse effects on M&A. Dale Stafford, a partner with Bain & Company's Mergers & Acquisitions practice in the Americas, appeared on Bloomberg Daybreak to discuss the opportunities for consolidation in the pharma and medtech sectors.